Skip to main content

. 1966 Jan;59(1):9–10. doi: 10.1177/003591576605900104

The significance of urinary hydroxyproline peptide excretion.

PMCID: PMC1900676 PMID: 5902384

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

JASIN H. E., FINK C. W., WISE W., ZIFF M. Relationship between urinary hydroxyproline and growth. J Clin Invest. 1962 Oct;41:1928–1935. doi: 10.1172/JCI104650. [DOI] [PMC free article] [PubMed] [Google Scholar]
JASIN H. E., ZIFF M. Relationship between soluble collagen and urinary hydroxyproline in the lathyritic rat. Proc Soc Exp Biol Med. 1962 Aug-Sep;110:837–841. doi: 10.3181/00379727-110-27665. [DOI] [PubMed] [Google Scholar]
SLEDGE C. B., DINGLE J. T. OXYGEN-INDUCED RESORPTION OF CARTILAGE IN ORGAN CULTURE. Nature. 1965 Jan 9;205:140–141. doi: 10.1038/205140a0. [DOI] [PubMed] [Google Scholar]
SMILEY J. D., ZIFF M. URINARY HYDROXYPROLINE EXCRETION AND GROWTH. Physiol Rev. 1964 Jan;44:30–44. doi: 10.1152/physrev.1964.44.1.30. [DOI] [PubMed] [Google Scholar]
WEISS L., DINGLE J. T. LYSOSOMAL ACTIVATION IN RELATION TO CONNECTIVE TISSUE DISEASE. Ann Rheum Dis. 1964 Jan;23:57–63. doi: 10.1136/ard.23.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
Webster G. R., Alpern R. J. Studies on the acylation of lysolecithin by rat brain. Biochem J. 1964 Jan;90(1):35–42. doi: 10.1042/bj0900035. [DOI] [PMC free article] [PubMed] [Google Scholar]
ZIFF M., KIBRICK A., DRESNER E., GRIBETZ H. J. Excretion of hydroxyproline in patients with rheumatic and non-rheumatic diseases. J Clin Invest. 1956 Jun;35(6):579–587. doi: 10.1172/JCI103311. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES